Senior insider sale
See Remarks at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$11.67M
407.09K shares
EDWARDS LARRY TODD plans to sell 407.09K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $11.67M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Employee Stock Purchase
Cash
Restricted Stock Vesting
NA
Restricted Stock Vesting
NA
Employee Stock Purchase
Cash
Restricted Stock Vesting
NA
Employee Stock Purchase
Cash
Restricted Stock Vesting
NA
Restricted Stock Vesting
NA
Employee Stock Purchase
Cash
Restricted Stock Vesting
NA
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/31/2026 | Employee Stock Purchase Cash | 448.00 | — |
3/1/2026 | Restricted Stock Vesting NA | 13.75K | — |
2/1/2026 | Restricted Stock Vesting NA | 4.95K | — |
11/30/2025 | Employee Stock Purchase Cash | 724.00 | — |
10/1/2025 | Restricted Stock Vesting NA | 10.50K | — |
5/31/2025 | Employee Stock Purchase Cash | 724.00 | — |
5/16/2025 | Restricted Stock Vesting NA | 22.55K | — |
2/1/2025 | Restricted Stock Vesting NA | 3.59K | — |
11/30/2024 | Employee Stock Purchase Cash | 1.09K | — |
5/16/2024 | Restricted Stock Vesting NA | 2.05K | — |
| Total | 60.38K | ||
Completed
Units to sell
291.69K
Market value
$8.30M
Units to sell
50.29K
Market value
$1.26M
Units to sell
4.73K
Market value
$123.8K
Planned — Approximate Date
Units to sell
60.38K
Market value
$1.99M
Units
407.09K
Value
$11.67M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/16/2026 | 291.69K | $8.30M | — | Completed |
9/16/2026 | 50.29K | $1.26M | — | Completed |
8/17/2026 | 4.73K | $123.8K | — | Completed |
| Planned — Approximate Date | ||||
10/20/2026 | 60.38K | $1.99M | NASDAQ | Planned |
| Total | 407.09K | $11.67M | ||